Texas Permanent School Fund Corp Has $5.72 Million Stock Position in Encompass Health Co. (NYSE:EHC)

Texas Permanent School Fund Corp lowered its stake in shares of Encompass Health Co. (NYSE:EHCFree Report) by 3.5% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 85,125 shares of the company’s stock after selling 3,131 shares during the period. Texas Permanent School Fund Corp owned approximately 0.08% of Encompass Health worth $5,717,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the stock. Victory Capital Management Inc. lifted its stake in Encompass Health by 0.8% during the 2nd quarter. Victory Capital Management Inc. now owns 1,083,510 shares of the company’s stock valued at $73,364,000 after acquiring an additional 8,606 shares in the last quarter. Oppenheimer & Co. Inc. grew its position in Encompass Health by 10.7% in the 3rd quarter. Oppenheimer & Co. Inc. now owns 113,501 shares of the company’s stock worth $7,623,000 after purchasing an additional 10,958 shares in the last quarter. Comerica Bank bought a new position in shares of Encompass Health during the 2nd quarter worth approximately $84,700,000. Virginia Retirement Systems ET AL purchased a new position in shares of Encompass Health in the 2nd quarter worth approximately $1,767,000. Finally, Principal Financial Group Inc. increased its position in shares of Encompass Health by 37.4% during the third quarter. Principal Financial Group Inc. now owns 517,501 shares of the company’s stock valued at $34,755,000 after acquiring an additional 140,930 shares during the last quarter. Institutional investors own 92.66% of the company’s stock.

Encompass Health Trading Down 0.7 %

NYSE:EHC opened at $72.93 on Monday. The company has a market cap of $7.31 billion, a P/E ratio of 21.02, a P/E/G ratio of 1.31 and a beta of 0.92. Encompass Health Co. has a 1 year low of $51.15 and a 1 year high of $76.84. The company has a debt-to-equity ratio of 1.19, a current ratio of 1.28 and a quick ratio of 1.27. The stock’s fifty day moving average price is $68.70 and its two-hundred day moving average price is $67.51.

Wall Street Analyst Weigh In

EHC has been the topic of several research analyst reports. Truist Financial boosted their price objective on Encompass Health from $82.00 to $86.00 and gave the stock a “buy” rating in a research report on Friday. Mizuho raised their price objective on shares of Encompass Health from $77.00 to $82.00 and gave the stock a “buy” rating in a report on Friday. Stephens reiterated an “overweight” rating and issued a $85.00 target price on shares of Encompass Health in a research note on Tuesday, January 16th. William Blair reissued an “outperform” rating on shares of Encompass Health in a research report on Wednesday, February 7th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $83.00 price target on shares of Encompass Health in a report on Friday. One research analyst has rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Buy” and an average target price of $79.89.

View Our Latest Stock Report on EHC

Encompass Health Profile

(Free Report)

Encompass Health Corporation provides post-acute healthcare services in the United States. It provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

Read More

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Co. (NYSE:EHCFree Report).

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.